GlassScriptPhysician profile
Blake Charlton
NPI 1982946315
$1,100.35
in general payments reported to CMS, 2019-2025
12 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.71 · 2020: $8.59 · 2021: $215 · 2022: $121 · 2023: $450 · 2024: $137 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $374.17 | 2021-2023 | Corevalve Evolut R |
| Boston Scientific Corporation | $152.11 | 2019-2024 | Stingray, Embold Fibered, Therasphere Administration Set |
| Abbott Laboratories | $116.17 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $112.82 | 2021-2025 | Camzyos, Eliquis |
| Teleflex LLC | $97.03 | 2024 | Turnpike |
| Amgen INC. | $70.47 | 2021-2024 | Repatha |
| Medline Industries LP | $48.82 | 2025 | |
| Novartis Pharmaceuticals Corporation | $47.50 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $25.14 | 2023 | Farxiga |
| Cardiovascular Systems INC. | $22.74 | 2019-2020 | |
| Terumo Medical Corporation | $19.54 | 2025 | Tr Band |
| Cleerly, INC. | $13.84 | 2025 | Cleerly Labs, Cleerly Ischemia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Charlton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.